# Comparison Between Natural Products and Chlorhexidine in Non-Surgical Periodontal Therapy: A Systematic Review of Randomized Clinical Trials

**Authors:** Andrea Scribante, Matteo Pellegrini, Maurizio Pascadopoli, Valentino Natoli, Valentina Poma, Andrea Butera

PMC · DOI: 10.3390/dj14020110 · Dentistry Journal · 2026-02-13

## TL;DR

This study compares natural products to chlorhexidine in treating gum disease, finding similar effectiveness with fewer side effects.

## Contribution

The study provides a systematic review of recent randomized trials comparing natural products and chlorhexidine in periodontal therapy.

## Key findings

- Natural products like Curcuma longa and Propolis showed comparable improvements in gum health to chlorhexidine.
- Natural treatments had fewer side effects such as staining and taste changes compared to chlorhexidine.
- Probiotic- and ozone-based treatments showed faster healing and favorable clinical outcomes.

## Abstract

Objectives: To evaluate the clinical effectiveness and safety of natural products compared with chlorhexidine (CHX) as adjuncts to non-surgical periodontal therapy (NSPT) in patients with periodontitis. Materials and Methods: This systematic review was conducted in accordance with the PRISMA 2020 guidelines and registered in PROSPERO (CRD420251133219). Electronic searches of PubMed, Scopus, and Web of Science were performed to identify randomized controlled trials (RCTs) published between 2020 and 2025. Eligible studies included adult patients with periodontitis treated with NSPT, comparing CHX-based products with natural formulations (mouthwashes, gels, irrigants, or dentifrices). Data extraction included product type, concentration, mode of application, follow-up duration, and primary periodontal outcomes. Study quality was assessed using the NIH Quality Assessment Tool. Results: Thirteen randomized controlled clinical trials met the inclusion criteria. Natural products such as Curcuma longa, Morus alba, Spirulina platensis, Propolis, Triphala, and Lycium barbarum demonstrated improvements in clinical attachment level (CAL) and probing pocket depth (PPD) comparable to those obtained with CHX, along with significant reductions in bleeding on probing (BoP) and plaque index (PI). Probiotic- and ozone-based treatments also showed favorable clinical outcomes, with faster healing and fewer adverse effects, such as tooth staining and taste alteration. Follow-up periods ranged from 14 days to 3 months. Conclusions: Natural products appear to be safe and effective alternatives to CHX when used as adjuncts to non-surgical periodontal therapy, providing comparable clinical benefits with a lower incidence of side effects. Nevertheless, further large-scale, long-term randomized trials are needed to standardize formulations and concentrations and to confirm the durability of these clinical effects.

## Linked entities

- **Chemicals:** chlorhexidine (PubChem CID 9552079)
- **Diseases:** periodontitis (MONDO:0005076)
- **Species:** Curcuma longa (taxon 136217), Morus alba (taxon 3498), Lycium barbarum (taxon 112863)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}
- **Diseases:** mucosal desquamation (MESH:D017490), alveolar bone resorption (MESH:D001862), Bleeding (MESH:D006470), attachment loss (MESH:D017622), halitosis (MESH:D006209), taste alteration (MESH:D004408), taste disturbance (MESH:D013651), Inflammatory (MESH:D007249), NSPT (MESH:D010518), complications (MESH:D008107), PPD (MESH:D005888), injury to (MESH:D014947), CAL (MESH:D019962), diabetes (MESH:D003920), mucosal irritation (MESH:D001523), calculus (MESH:D002137), hypersensitivity (MESH:D004342), mucositis (MESH:D052016), peri-implant diseases (MESH:D057873), Type 2 Diabetes Mellitus (MESH:D003924), periodontal disease (MESH:D010510), tooth (MESH:D014076), tooth staining (MESH:D019339), gingivitis (MESH:D005891), cardiovascular disease (MESH:D002318)
- **Chemicals:** phenolic acids (MESH:C017616), CHX (MESH:D002710), alkaloids (MESH:D000470), gallic acid (MESH:D005707), polysaccharides (MESH:D011134), Polyphenol (MESH:D059808), reactive oxygen species (MESH:D017382), flavonoids (MESH:D005419), Curcumin (MESH:D003474), BoP (-), Ozone (MESH:D010126), tannins (MESH:D013634), Propolis (MESH:D011429)
- **Species:** Piper betle (species) [taxon 13217], Candida albicans (species) [taxon 5476], Limnospira platensis (species) [taxon 118562], Lycium barbarum (Duke of Argyll's teatree, species) [taxon 112863], Morus alba (white mulberry, species) [taxon 3498], Salvadora persica (species) [taxon 4326], Curcuma longa (turmeric, species) [taxon 136217], Porphyromonas gingivalis (species) [taxon 837], Homo sapiens (human, species) [taxon 9606], Matricaria chamomilla (species) [taxon 98504]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12939140/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939140/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12939140/full.md

---
Source: https://tomesphere.com/paper/PMC12939140